全部

1·The emergence of resistant strains during therapy greatly increases the risk of a poor clinical outcome, including death.

治疗期间出现耐药菌株会大大增加临床疗效不佳，包括死亡的风险。

2·High levels of Snail have been linked to metastasis, tumor cell survival and tumor recurrence, and thus predict a poor clinical outcome for women with breast cancer.

Snail表达增高与转移、肿瘤细胞生存和肿瘤复发密切相关，因此可预测乳腺癌病人具有较差的临床结局。

3·Results: in all the 183 patients with surgical treatment, 126 achieved satisfactory outcome, and 44 got good outcome, while other 13 patients had poor clinical outcome.

结果：183例体表血管瘤患者经外科手术治疗后，治愈126例，控制良好44例，疗效不佳13例。

4·Conclusions: Patients are likely to experience poor clinical outcome, ultimately requiring total hip arthroplasty, when salvage procedures are delayed by more than 3 weeks.

结论：创伤3周以上再行补救性手术时，患者临床疗效较差，最终需要行全髋关节置换术。

5·UCD has a good prognosis after surgery, while MCD often poorly responds to chemotherapy and has a relatively poor prognosis. New drugs and clinical trials are needed to improve the outcome of MCD.

UCD患者手术治疗的疗效和预后较好，MCD患者化疗效果欠佳，预后相对较差，需要尝试新的治疗手段。